Skip to main content
HMELF
OTC Technology

Hold Me Ltd. Reports Zero Revenue, Going Concern Doubt, and Material Weaknesses in 2025 Annual Report

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
10
Price
$0.01
Mkt Cap
0
52W Low
$0.01
52W High
$6.5
Market data snapshot near publication time

summarizeSummary

Hold Me Ltd.'s 2025 annual report highlights zero revenue, a worsening financial position with a substantial accumulated deficit, and significant doubt about its ability to continue as a going concern, further complicated by material weaknesses in internal controls and corporate governance non-compliance.


check_boxKey Events

  • Zero Revenue in 2025

    The company reported no revenues for the fiscal year ended December 31, 2025, a decline from NIS 55,845 in 2024, indicating a complete lack of commercialization for its products.

  • Going Concern Doubt

    Management and the independent auditors have expressed substantial doubt about the company's ability to continue as a going concern due to recurring losses, negative cash flows, and an accumulated deficit of NIS 4,724,346 (approximately $1.23 million).

  • Material Weaknesses in Internal Controls

    Several material weaknesses were identified in internal control over financial reporting, including a lack of qualified accounting staff, insufficient documented financial closing procedures, and absence of an audit committee and independent directors.

  • Worsening Financial Position

    The company's net loss increased to NIS 931,888 in 2025 from NIS 758,216 in 2024, and its cash balance is critically low at NIS 13,720 (approximately $3,567).


auto_awesomeAnalysis

Hold Me Ltd.'s 2025 annual report reveals a company in severe financial distress, with zero revenue for the year and a significant accumulated deficit. The auditors have issued a going concern warning, indicating substantial doubt about the company's ability to continue operations. Compounding these issues are identified material weaknesses in internal financial reporting controls and non-compliance with several Israeli corporate governance requirements. The CEO's multiple roles in other companies also raise concerns about management focus and potential conflicts of interest. These factors, alongside geopolitical risks affecting its Israel-based operations, paint a dire picture for the company, which is currently trading at its 52-week low.

At the time of this filing, HMELF was trading at $0.01 on OTC in the Technology sector. The 52-week trading range was $0.01 to $6.50. This filing was assessed with negative market sentiment and an importance score of 10 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed HMELF - Latest Insights

HMELF
May 14, 2026, 5:00 PM EDT
Filing Type: 20-F
Importance Score:
10